INTCO MEDICAL(300677)2025-01-23 09:26Financial Performance - The company expects net profit attributable to shareholders to be between RMB 1.2 billion and RMB 1.5 billion for 2024, representing a year-on-year increase of 213.32% to 291.65% compared to RMB 382.9976 million in the previous year[3]. - The net profit after deducting non-recurring gains and losses is projected to be between RMB 950 million and RMB 1.2 billion, reflecting a significant increase of 989.85% to 1276.66% from RMB 87.1677 million in the same period last year[3]. - The financial data in the earnings forecast is preliminary and has not been audited, with detailed financial results to be disclosed in the 2024 annual report[9]. - The company encourages investors to make cautious decisions and be aware of investment risks[10]. Production and Capacity - The company achieved a production capacity utilization rate of 100% during the reporting period, benefiting from industry supply structure optimization and increased demand[7]. - The company reported an increase in the average selling price of disposable nitrile gloves compared to the same period last year, contributing to improved revenue[7]. Strategic Initiatives - The company has implemented a talent strategy, including campus recruitment and the "Inco Young" program, to continuously inject new talent into its workforce[7]. - The company is focused on digitalization, information technology, and intelligent transformation to effectively reduce production costs and enhance profitability[7]. - The appreciation of the US dollar in 2024 positively impacted the company's performance, highlighting its strategic vision and risk management capabilities in global market expansion[8]. Organizational Culture - The company emphasizes a culture of healthy competition through mechanisms like "competition" and "racehorse" to enhance overall team capabilities[7].